Editor: What To Know
- In 2021, the congenital heart defect closure devices segment accounted for the highest revenue share due to a rising understanding of the importance of paediatric interventional cardiology devices and rising instances of congenital impairments.
- The increased rates of congenital heart disease and FDA initiatives to streamline the regulatory process, technical advances, which have resulted in the introduction of new and improved products is expected to drive the market.
- Regional MarketsIn 2021, Asia Pacific region accounted for the highest revenue in the paediatric interventional cardiology market and is expected to maintain its dominance during the forecast period.
The “Paediatric Interventional Cardiology Market Analysis by Device Type and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The paediatric interventional cardiology market size is estimated to be USD 1,581.3 million in 2021 and is expected to witness a CAGR of 11.18% during the forecast period 2022-2029.
Companies Mentioned:
- St. Jude Medical Inc. (U.S.)
- Medtronic Inc. (U.S.)
- W.L. Gore & Associates Inc. (U.S.)
- Edwards Lifesciences Corp (U.S.)
- NuMED Inc. (U.S.)
- Cordis Corporation (U.S.)
- GE Healthcare (U.K.)
- Siemens Healthcare (Germany)
- Boston Scientific (U.S.)
- Abbott Vascular (U.S.)
The increased rates of congenital heart disease and FDA initiatives to streamline the regulatory process, technical advances, which have resulted in the introduction of new and improved products is expected to drive the market.
However, changing stringency of regulatory procedures and presence of complex regulatory procedures is expected to restrain the market growth.
By Device Type
Based on device type, the market is segregated into transcatheter heart valves and congenital heart defect closure devices. In 2021, the congenital heart defect closure devices segment accounted for the highest revenue share due to a rising understanding of the importance of paediatric interventional cardiology devices and rising instances of congenital impairments.
Regional Markets
In 2021, Asia Pacific region accounted for the highest revenue in the paediatric interventional cardiology market and is expected to maintain its dominance during the forecast period. The increase in government funding for developing paediatric care facilities, and investments by prominent players in the APAC region. are all contributing to the market expansion.
Segmentation: Paediatric Interventional Cardiology Market Report 2021-2029
By Device Type (Revenue, USD Million)
- Transcatheter Heart Valves
- Congenital Heart Defect Closure Devices
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/an873x
